1,5-Dimethyl-1H-pyrazole-3-carboxamide, 97.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,4-dimethylpentanoic acid, 95.0%, 500mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)amino)propanoic acid, 97%, 1g

Boc-Lys(Ac)-OH, 97%, 25g

8-Bromo-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 95%, 5g

4-Methyloxazole-5-carboxylic acid, 97.0%, 1g

2-[5-[(Acryloyloxy)methyl]-5-ethyl-1,3-dioxan-2-yl]-2-methylpropyl Acrylate (cis- and trans- mixture) (stabilized with MEHQ)>95.0%(qNMR)500g

5-Chloro-1H-indazole-3-carbaldehyde, 95.0%, 1g

N,N-DIETHYL-2-METHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZAMIDE, 95%, 1g

Tris(dibenzylideneacetone)dipalladium(0)>75.0%(T)5g

1-(4-Methoxyphenyl)cyclobutanecarbonitrile, 97.0%, 100mg

2-Methoxytoluene>98.0%(GC)500mL

1-Methyl-3-thien-2-yl-1H-pyrazole-5-carboxylic acid, 95.0%, 2.5g